PAOLINI, ERIKA

PAOLINI, ERIKA  

Dipartimento di Scienze Farmacologiche e Biomolecolari  

Mostra records
Risultati 1 - 11 di 11 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution 1-feb-2022 Miriam LongoErika Paolini + Article (author) -
The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation 1-mar-2021 Longo M.Valenti L.Paolini E.Fracanzani A. L.Dongiovanni P. + Article (author) -
Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients with Nonalcoholic Fatty Liver Disease 1-gen-2021 Longo M.Lombardi R.Paolini E.Macchi C.Corsini A.Fracanzani A. L.Ruscica M. + Article (author) -
Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending? 1-apr-2021 Longo M.Meroni M.Paolini E.Macchi C.Dongiovanni P. Article (author) -
NAFLD or MAFLD diagnoses and cardiovascular diseases: from epidemiology to drug approaches 1-lug-2021 Paolini, E.Corsini, A.Ruscica, M. + Article (author) -
Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system 22-feb-2022 M. MeroniE. PaoliniM. LongoR. PiciottiS. FargionP. Dongiovanni + Article (author) -
Remodeling of mitochondrial plasticity: The key switch from NAFLD/Nash to HCC 17-apr-2021 Longo M.Paolini E.Dongiovanni P. + Article (author) -
The rs599839 a>g variant disentangles cardiovascular risk and hepatocellular carcinoma in nafld patients 1-gen-2021 Meroni M.Longo M.Paolini E.Miele L.Pisano G.Fracanzani A. L.Dongiovanni P. + Article (author) -
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models 1-gen-2022 Miriam LongoMarica MeroniErika PaoliniFrancesco FortunatoDario RonchiRoberto PiciottiChiara MacchiGiacomo Pietro ComiLuca ValentiMassimiliano RuscicaAnna L. FracanzaniPaola Dongiovanni + Article (author) -
$\upalpha$-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study [alpha-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study] 1-set-2021 Miriam LongoErika PaoliniMarica MeroniLorena DucaIrene MottaAnna Ludovica FracanzaniElena Di PierroPaola Dongiovanni Article (author) -
The α-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study 4-ago-2021 Miriam LongoErika PaoliniMarica MeroniLorena DucaIrene MottaAnna L. FracanzaniElena Di PierroPaola Dongiovanni Article (author) -